Bookmark

Add to MyYahoo RSS

Lexicon Pharmaceuticals News

News on Lexicon Pharmaceuticals (Ticker: LXRX) continually updated from thousands of sources around the net.

Tuesday Aug 19 | AmericanBankingNews.com

Gabelli Lowers Lexicon Pharmaceuticals to Hold

Shares of Lexicon Pharmaceuticals opened at 1.64 on Tuesday. Lexicon Pharmaceuticals has a 1-year low of $1.25 and a 1-year high of $3.18.

Comment?

Related Topix: Biotech, Lexicon Genetics, Medicine, Healthcare Industry

Tue Aug 12, 2014

Seeking Alpha

For Lexicon Pharmaceuticals, No News Remains Bad News

Lexicon updates investors on its second quarter results, but still has no partner to develop LX4211 in Type 2 diabetes.

Comment?

Related Topix: Biotech, Medicine, Lexicon Genetics, Healthcare Industry, Diabetes, Health, Arena Pharmaceuticals, Johnson and Johnson, AstraZeneca Group

Mon Aug 11, 2014

Seeking Alpha

For Lexicon Pharmaceuticals, No News Remains Bad News

Lexicon updates investors on its second quarter results, but still has no partner to develop LX4211 in Type 2 diabetes.

Comment?

Related Topix: Biotech, Medicine, Lexicon Genetics, Healthcare Industry, Diabetes, Health, Arena Pharmaceuticals, Johnson and Johnson, AstraZeneca Group

Thu Aug 07, 2014

BioSpace

Lexicon Pharmaceuticals, Inc. Provides Clinical Pipeline Update And...

"I have spent the better part of this past month reviewing the progress of our two lead programs, LX4211 and telotristat etiprate," said Lonnel Coats , Lexicon's newly appointed president and chief executive officer.

Comment?

Related Topix: Biotech, Medicine, Lexicon Genetics, Healthcare Industry

Tue Aug 05, 2014

Sys-Con Media

Lexicon To Report Second Quarter 2014 Financial Results On August 7, 2014

Lexicon management will hold a conference call and webcast to discuss clinical development progress and financial results for the second quarter 2014 at ) or 970-300-1531 .

Comment?

Related Topix: Biotech, Medicine, Lexicon Genetics, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••